Detect Inc. receives $8.1M NIH contract for Covid-19 test manufacturing

Detect Inc. announced that the NIH selected its Detect Covid-19 Test to receive $8.1 million in funding from the RADx initiative to facilitate development and scale up manufacturing of its PCR-quality rapid at-home Covid-19 test.

“The $8.1 million contract will facilitate the development and scale up manufacturing of Detect's PCR-quality rapid at-home Covid-19 test to meet national testing demand.”biospace.com

• 1 source
• biospace.comDetect™ Selected by NIH to Scale Manufacturing of PCR-Quality Rapid At-Home Covid-19 Test - BioSpaceHeather McKenzieOct 14, 2021

Summarized from public sources; check the original articles before acting on it.